NASDAQ Respiratory Medicine Market News

Athersys Reports Financial Results for Fourth Quarter, Full Year 2017

Company also announces equity investment and binding letter of intent to expand HEALIOS K.K. collaboration, ...

Immunovaccine to Host Investor Event on April 10, 2018 in New York City

HALIFAX, Nova Scotia, March 13, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a ...

Immunovaccine to Host Investor Event on April 10, 2018 in New York City

HALIFAX, Nova Scotia, March 13, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a ...

Athersys Reports Financial Results for Fourth Quarter, Full Year 2017

Company also announces equity investment and binding letter of intent to expand HEALIOS K.K. collaboration, ...

Athersys and HEALIOS Announce Binding Letter of Intent to Expand MultiStem® Collaboration

Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive ...

Athersys and HEALIOS Announce Binding Letter of Intent to Expand MultiStem® Collaboration

Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive ...

Athersys and Healios Announce Binding Letter of Intent to Expand MultiStem® Collaboration

Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive ...

Athersys and Healios Announce Binding Letter of Intent to Expand MultiStem® Collaboration

Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive ...